# A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults

> **NCT02994381** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** RPC1063

## Key facts

- **NCT ID:** NCT02994381
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02994381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02994381, "A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02994381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*